CCOYX | RSIFX | CCOYX / RSIFX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 8 years | 29 years | - |
Gain YTD | 15.071 | 35.887 | 42% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 2500 | 40,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 14.3B | 209M | 6,842% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 14.82 | 37.86 | 39% |
Returns for 3 years | 4.80 | -2.79 | -172% |
Returns for 5 years | 68.91 | 17.58 | 392% |
Returns for 10 years | N/A | 50.22 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GNOM | 9.89 | 0.19 | +1.96% |
Global X Genomics & Biotechnology ETF | |||
PSFO | 28.84 | 0.21 | +0.73% |
Pacer Swan SOS Flex (October) ETF | |||
GAPR | 37.39 | 0.16 | +0.44% |
FT Vest U.S. Eq Mod Buf ETF - Apr | |||
GSID | 54.11 | -0.21 | -0.38% |
Goldman Sachs MarketBeta Intl Eq ETF | |||
VIGI | 79.93 | -0.49 | -0.61% |
Vanguard Intl Div Apprec ETF |